Objective
73100 have developed and patented a novel bacterial fermented biopolymer – FucoPol – as a natural source for the efficient production of pure L-fucose. L-fucose is a rare monosaccharide with limited natural availability and a precursor of complex carbohydrates, as Human Milk Oligosaccharides (HMOs). HMOs, which are highly abundant in human milk but not in infant formula, have been recently recognised as natural molecules with high potential for nutritional and biomedical applications. Despite the increasing market demand of these “specialty carbohydrates”, a large scale production of HMOs is currently not feasible. Current technologies are hindered by the complexity and costs related to the attempt to increase the availability of the core component L-fucose. In fact, this monosaccharide acts as building block for HMOs, representing over 60-70% of the oligosaccharides portion in human milk. FucoPol – as natural source of pure monosaccharides - solves the main industrial issues related to L-fucose production such as the complexity, costs and efficiency. FucoPol bio-based platform offers a sustainable solution for industrial-commercialization of HMOs, by significantly increasing L-fucose availability. Accomplishing the innovation project objectives will result in the production of large amount of high-pure L-fucose to meet the quality/quantity industrial demand for this rare sugar. L-fucose commercialization will target HMOs manufacturing companies, for the production of: 1) Infant food formula (milk bioactives) 2) Fortified and functional food/beverages 3) Health ingredients for human and animal 3) Over the counter food supplements.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- engineering and technologyother engineering and technologiesfood technology
- engineering and technologyindustrial biotechnology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- natural sciencesbiological sciencesbiochemistrybiomoleculescarbohydrates
You need to log in or register to use this function
Programme(s)
- H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme
- H2020-EU.3.2.4. - Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy
- H2020-EU.3.2.1. - Sustainable agriculture and forestry
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.2.2. - Sustainable and competitive agri-food sector for a safe and healthy diet
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
7040-220 IGREJINHA EVORA
Portugal
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.